Comment on 'Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study'

被引：0
|
作者：
Zhu, Xudong [1 ,2 ]
机构：
[1] China Med Univ, Dalian Univ Technol, Liaoning Canc Hosp & Inst, Dept Gen Surg,Canc Hosp, Shenyang, Liaoning, Peoples R China
[2] Liaoning Prov Key Lab Precis Med Malignant Tumors, Shenyang, Liaoning, Peoples R China
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2025年 / 13卷 / 03期
关键词：
Immunotherapy; Lung Cancer;
D O I：
10.1136/jitc-2025-011845
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study
    Smeenk, Michiel M.
    van der Noort, Vincent
    Hendrikx, Jeroen M. A.
    Kalkhoran, Hanieh Abedian
    Smit, Egbert F.
    Theelen, Willemijn S. M. E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)
  • [2] Real-world monitoring of hybrid dosing of pembrolizumab in stage IV non-small cell lung cancer in the Netherlands
    Dronkers, E.
    Van Geffen, E.
    Bekkers, C.
    Sobels, A.
    van Drie-Pierik, R.
    Eldering-Heldens, A.
    Zwaveling, J.
    Eijsink, J.
    Smit, H. J. M.
    Hilarius, D.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S73 - S73
  • [3] Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective
    Grit, Geeske F.
    van Geffen, Esmee
    Malmberg, Ruben
    van Leeuwen, Roelof
    Bohringer, Stefan
    Smit, Hans J. M.
    Brocken, Pepijn
    Eijsink, Job F. H.
    Dronkers, Esther
    Gal, Pim
    Jaarsma, Eva
    van Drie-Pierik, Regine J. H. M.
    Eldering-Heldens, Anne M. P.
    Wymenga, A. N. Machteld
    Mol, Peter G. M.
    Zwaveling, Juliette
    Hilarius, Doranne
    LUNG CANCER, 2024, 196
  • [4] Real-World Overall Survival After Alternative Dosing for Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study with a Non-Inferiority Primary Objective
    Grit, Geeske F.
    van Geffen, Esmee
    Malmberg, Ruben
    van Leeuwen, Roelof
    Bohringer, Stefan
    Smit, Hans J. M.
    Brocken, Pepijn
    Eijsink, Job F. H.
    Dronkers, Esther
    Gal, Pim
    Jaarsma, Eva
    van Drie-Pierik, Regine J. H. M.
    Eldering-Heldens, Anne M. P.
    Wymenga, Machteld
    Mol, Peter G. M.
    Zwaveling, Juliette
    Hilarius, Doranne
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 331 - 331
  • [5] Real-world evidence for pembrolizumab in non-small cell lung cancer: a nationwide cohort study
    Hektoen, Helga H.
    Tsuruda, Kaitlyn M.
    Fjellbirkeland, Lars
    Nilssen, Yngvar
    Brustugun, Odd Terje
    Andreassen, Bettina K.
    BRITISH JOURNAL OF CANCER, 2025, 132 (01) : 93 - 102
  • [6] Pembrolizumab monotherapy or combination therapy for bone metastases in advanced non-small cell lung cancer: a real-world retrospective study
    Qiang, Huiping
    Lei, Yuqiong
    Shen, Yinchen
    Li, Jiaqi
    Zhong, Hua
    Zhong, Runbo
    Zhang, Xueyan
    Chang, Qing
    Lu, Jiahuan
    Feng, Hui
    Zhu, Yan
    Addeo, Alfredo
    Banna, Giuseppe L.
    Oh, In-Jae
    Qian, Jialin
    Chu, Tianqing
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (01) : 87 - 99
  • [7] Safety of pembrolizumab in patients with non-small cell lung cancer: a real-world study
    Thakrar, D. B.
    Essang, B.
    Echlin, A.
    Murdock, C.
    Lind, M. J.
    LUNG CANCER, 2019, 127 : S40 - S41
  • [8] Real-world efficacy and safety of pembrolizumab in patients with non-small cell lung cancer: a retrospective observational study
    Cavaille, Francois
    Peretti, Mathieu
    Garcia, Marie Eve
    Giorgi, Roch
    Ausias, Nathalie
    Vanelle, Patrice
    Barlesi, Fabrice
    Montana, Marc
    TUMORI JOURNAL, 2021, 107 (01): : 32 - 38
  • [9] TP53 Mutation Mapping in Advanced Non-Small Cell Lung Cancer: A Real-World Retrospective Cohort Study
    Hao, Fang
    Gu, Liyan
    Zhong, Diansheng
    CURRENT ONCOLOGY, 2022, 29 (10) : 7411 - 7419
  • [10] A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations
    Lei, Lei
    Wang, Wen-xian
    Yu, Zong-yang
    Liang, Xian-bin
    Pan, Wei-wei
    Chen, Hua-fei
    Wang, Li-ping
    Fang, Yong
    Wang, Min
    Xu, Chun-wei
    Fang, Mei-yu
    TRANSLATIONAL ONCOLOGY, 2020, 13 (02): : 329 - 335
12345